ID
37962
Description
Study ID: 104864/627 Clinical Study ID: 104864/627 Study Title: An Open-label, Multicenter, Non-Comparative Phase II Study of the Combination of Intravenous Topotecan and Gemcitabine Administered Once Weekly for Three Weeks Every 28 Days as Second-line Treatment in Patients With Recurrent Platinum Sensitive Ovarian Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00061308 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan, Gemcitabine Study Indication: Peritoneal Cancer, Ovarian Cancer, Neoplasms, Ovarian, Fallopian Tube Cancer
Keywords
Versions (1)
- 9/2/19 9/2/19 -
Copyright Holder
GlaxoSmithKline
Uploaded on
September 2, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Intravenous Topotecan and Gemcitabine as Second-line Treatment in Patients With Ovarian Cancer NCT00061308
Course -- Prior to next Course (Day 25 - 28) - Review of Disease Status; Therapeutic Interventions; End of Course Eligibility; Unscheduled Laboratory Tests; Therapeutic Interventions Log
Description
Review of Disease Status
Alias
- UMLS CUI-1
- C0699749
- UMLS CUI-2
- C0699752
Description
Date of Assessment
Data type
date
Alias
- UMLS CUI [1]
- C2985720
Description
Assessment not done
Data type
integer
Alias
- UMLS CUI [1,1]
- C0220825
- UMLS CUI [1,2]
- C1272696
Description
Mark only one
Data type
integer
Alias
- UMLS CUI [1,1]
- C0220825
- UMLS CUI [1,2]
- C2826287
Description
Date of Progression
Data type
date
Alias
- UMLS CUI [1,1]
- C0242656
- UMLS CUI [1,2]
- C0011008
Description
Mark one
Data type
integer
Alias
- UMLS CUI [1,1]
- C0221198
- UMLS CUI [1,2]
- C1516048
- UMLS CUI [2]
- C4534461
Description
Therapeutic Interventions
Alias
- UMLS CUI-1
- C0808232
Description
End of Course Eligibility
Alias
- UMLS CUI-1
- C0013893
- UMLS CUI-2
- C0750729
- UMLS CUI-3
- C0444930
Description
Hemoglobin >= 9.0 g/dL [90 g/L] Neutrophils >= 1000 cells/mm3 [>= 1.0 x 10*9 /L] Platelets >= 100,000/mm3 [>= 100.0 x 10*9 /L] No clinically significant non-hematologic drug related toxicity If "Yes“, proceed to next course. If "No”, complete Unscheduled Laboratory Tests.
Data type
boolean
Alias
- UMLS CUI [1]
- C0013893
Description
Unscheduled Laboratory Tests - Hematology
Alias
- UMLS CUI-1
- C0022885
- UMLS CUI-2
- C3854240
- UMLS CUI-3
- C0474523
Description
Unscheduled Laboratory Tests - Hematology
Alias
- UMLS CUI-1
- C0022885
- UMLS CUI-2
- C3854240
- UMLS CUI-3
- C0474523
Description
Hematology Test
Data type
integer
Alias
- UMLS CUI [1]
- C0018941
Description
Hematology - No Result
Data type
integer
Alias
- UMLS CUI [1,1]
- C0018941
- UMLS CUI [1,2]
- C1274040
Description
Hematology - Value
Data type
text
Alias
- UMLS CUI [1]
- C0474523
Description
Hematology - Value out of range and NOT clinically significant
Data type
integer
Alias
- UMLS CUI [1,1]
- C0474523
- UMLS CUI [1,2]
- C0438215
- UMLS CUI [1,3]
- C2826293
Description
Hematology - Value out of range and clinically significant
Data type
integer
Alias
- UMLS CUI [1,1]
- C0474523
- UMLS CUI [1,2]
- C0438215
- UMLS CUI [1,3]
- C2826293
Description
Therapeutic Interventions
Alias
- UMLS CUI-1
- C0808232
Description
Line Number
Data type
integer
Alias
- UMLS CUI [1]
- C0449788
Description
Procedure
Data type
text
Alias
- UMLS CUI [1]
- C2700391
Description
Procedure details
Data type
text
Alias
- UMLS CUI [1,1]
- C2700391
- UMLS CUI [1,2]
- C1522508
Description
Procedure Time
Data type
time
Alias
- UMLS CUI [1,1]
- C2700391
- UMLS CUI [1,2]
- C0040223
Description
Procedure Date
Data type
date
Alias
- UMLS CUI [1,1]
- C2700391
- UMLS CUI [1,2]
- C0011008
Similar models
Course -- Prior to next Course (Day 25 - 28) - Review of Disease Status; Therapeutic Interventions; End of Course Eligibility; Unscheduled Laboratory Tests; Therapeutic Interventions Log
C0600091 (UMLS CUI [1,2])
C0750729 (UMLS CUI [1,2])
C0699752 (UMLS CUI-2)
C1272696 (UMLS CUI [1,2])
C2826287 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C1516048 (UMLS CUI [1,2])
C4534461 (UMLS CUI [2])
C0013221 (UMLS CUI [2,1])
C0304229 (UMLS CUI [2,2])
C0750729 (UMLS CUI-2)
C0444930 (UMLS CUI-3)
C3854240 (UMLS CUI-2)
C0474523 (UMLS CUI-3)
C1302413 (UMLS CUI [1,2])
C3258037 (UMLS CUI [1,2])
C3854240 (UMLS CUI-2)
C0474523 (UMLS CUI-3)
C1274040 (UMLS CUI [1,2])
C0438215 (UMLS CUI [1,2])
C2826293 (UMLS CUI [1,3])
C0438215 (UMLS CUI [1,2])
C2826293 (UMLS CUI [1,3])
C1522508 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
No comments